Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347788
Filing Date
2012-08-09
Accepted
2012-08-09 16:49:11
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d347443d10q.htm 10-Q 800893
2 EX-10.1 d347443dex101.htm EX-10.1 349819
3 EX-31.1 d347443dex311.htm EX-31.1 6094
4 EX-31.2 d347443dex312.htm EX-31.2 5958
5 EX-32.1 d347443dex321.htm EX-32.1 4327
6 EX-32.2 d347443dex322.htm EX-32.2 4316
  Complete submission text file 0001193125-12-347788.txt   3854732

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT zgnx-20120630.xml EX-101.INS 420601
8 XBRL TAXONOMY EXTENSION SCHEMA zgnx-20120630.xsd EX-101.SCH 29221
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zgnx-20120630_cal.xml EX-101.CAL 41629
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zgnx-20120630_def.xml EX-101.DEF 109703
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE zgnx-20120630_lab.xml EX-101.LAB 239912
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zgnx-20120630_pre.xml EX-101.PRE 168855
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 650 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 650 SAN DIEGO CA 92130 (858) 259-1165
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

EIN.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34962 | Film No.: 121021012
SIC: 2834 Pharmaceutical Preparations